ROBINS AH
Big PharmaROBINS AH is a major pharmaceutical company focused on Cardiovascular, Gastroenterology.
ROBINS AH's Key Drugs
ROBINS AH's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
ROBINS AH's Recent FDA Approvals
New NDA/BLA approvals for ROBINS AH over the last two years — novel drugs only, excluding generics and label supplements.
ROBINS AH's Therapeutic Areas
ROBINS AH's approved drugs and pipeline span 2 therapeutic areas, led by Cardiovascular and Gastroenterology, across 0 biologic and 2 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
ROBINS AH's Top Competitors
ROBINS AH's closest competitors by therapeutic-area and drug-target overlap include BAUSCH, Takeda, and APOTHECON. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
ROBINS AH Pipeline Snapshot
Active clinical trials for ROBINS AH across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1960-04-15
- Latest
- 2004-02-10
- Applications
- 10